The stock of Beauty Health Company (SKIN) has gone down by -43.85% for the week, with a -55.67% drop in the past month and a -65.89% drop in the past quarter. The volatility ratio for the week is 25.25%, and the volatility levels for the past 30 days are 11.78% for SKIN. The simple moving average for the past 20 days is -41.65% for SKIN’s stock, with a -74.57% simple moving average for the past 200 days.

Is It Worth Investing in Beauty Health Company (NASDAQ: SKIN) Right Now?

Moreover, the 36-month beta value for SKIN is 0.83. Analysts have varying opinions on the stock, with 3 analysts rating it as a “buy,” 1 as “overweight,” 6 as “hold,” and 3 as “sell.”

The average price recommended by analysts for Beauty Health Company (SKIN) is $3.44, which is $1.25 above the current market price. The public float for SKIN is 86.68M and currently, short sellers hold a 28.90% of that float. On November 20, 2023, SKIN’s average trading volume was 4.47M shares.

SKIN) stock’s latest price update

The stock of Beauty Health Company (NASDAQ: SKIN) has decreased by -3.10 when compared to last closing price of 2.26.Despite this, the company has seen a loss of -43.85% in its stock price over the last five trading days. InvestorPlace reported 2023-11-14 that Beauty Health (NASDAQ: SKIN ) stock is taking a beating on Tuesday after the aesthetic technologies and products company released its Q3 earnings report. The bad news for SKIN stock starts with the company’s revenue of $97.4 million.

Analysts’ Opinion of SKIN

Many brokerage firms have already submitted their reports for SKIN stocks, with Jefferies repeating the rating for SKIN by listing it as a “Hold.” The predicted price for SKIN in the upcoming period, according to Jefferies is $1.50 based on the research report published on November 15, 2023 of the current year 2023.

SKIN Trading at -55.76% from the 50-Day Moving Average

After a stumble in the market that brought SKIN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -84.24% of loss for the given period.

Volatility was left at 11.78%, however, over the last 30 days, the volatility rate increased by 25.25%, as shares sank -52.69% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -59.78% lower at present.

During the last 5 trading sessions, SKIN fell by -43.59%, which changed the moving average for the period of 200-days by -82.95% in comparison to the 20-day moving average, which settled at $3.63. In addition, Beauty Health Company saw -75.93% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at SKIN starting from Miller Brian Christopher, who purchase 60,000 shares at the price of $5.81 back on Aug 17. After this action, Miller Brian Christopher now owns 91,450 shares of Beauty Health Company, valued at $348,600 using the latest closing price.

CAPELLAS MICHAEL D, the Director of Beauty Health Company, purchase 30,000 shares at $6.03 during a trade that took place back on Aug 17, which means that CAPELLAS MICHAEL D is holding 197,612 shares at $180,948 based on the most recent closing price.

Stock Fundamentals for SKIN

Current profitability levels for the company are sitting at:

• -0.83 for the present operating margin
• +66.78 for the gross margin

The net margin for Beauty Health Company stands at +12.13. The total capital return value is set at -0.31, while invested capital returns managed to touch 4.52. Equity return is now at value -51.13, with -8.56 for asset returns.

Based on Beauty Health Company (SKIN), the company’s capital structure generated 439.48 points at debt to equity in total, while total debt to capital is 81.46. Total debt to assets is 74.70, with long-term debt to equity ratio resting at 435.53. Finally, the long-term debt to capital ratio is 80.73.

When we switch over and look at the enterprise to sales, we see a ratio of 1.21, with the company’s debt to enterprise value settled at 0.49. The receivables turnover for the company is 5.66 and the total asset turnover is 0.33. The liquidity ratio also appears to be rather interesting for investors as it stands at 10.79.

Conclusion

To wrap up, the performance of Beauty Health Company (SKIN) has been bad in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.